Concepedia
Statistics
Publications
17
Citations
2.7K
H-Index
Active since
2011
Affiliations
Massachusetts General Hospital(Current)
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Harvard University
Cornell University
Harper Hubbeling is an author at Massachusetts General Hospital specializing in oncology, medicine, and lung cancer.
Publications per year
2011–2024
The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C− monocytes
Richard N. Hanna, Leo M. Carlin, Harper Hubbeling et al. · Nature Immunology · 2011 · 626 citations · Full text
Life Sciences, Genetics, Molecular Biology +6
NR4A1 (Nur77) Deletion Polarizes Macrophages Toward an Inflammatory Phenotype and Increases Atherosclerosis
Richard N. Hanna, Iftach Shaked, Harper Hubbeling et al. · Circulation Research · 2011 · 453 citations · Full text
Life Sciences, Immunology, Molecular Biology +15
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer
Satoshi Yoda, Michael S. Lawrence, Benjamin J. Burke et al. · Cancer Discovery · 2018 · 306 citations · Full text
Medicine, Molecular Medicine, Oncology +16
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer
Justin F. Gainor, Diane Tseng, Satoshi Yoda et al. · JCO Precision Oncology · 2017 · 261 citations
Medicine, Oncology, Pharmacology +17
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation Diversity
Ibiayi Dagogo‐Jack, Marguerite Rooney, Rebecca J. Nagy et al. · Clinical Cancer Research · 2019 · 150 citations · Full text
1–5 of 17